BioSyent Inc. (OTCMKTS:BIOYF) Sees Significant Decrease in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 100 shares, a drop of 66.7% from the March 15th total of 300 shares. Based on an average daily trading volume, of 1,000 shares, the days-to-cover ratio is presently 0.1 days.

BioSyent Trading Up 2.8 %

Shares of OTCMKTS:BIOYF opened at $7.57 on Thursday. The business’s 50-day simple moving average is $7.66 and its 200 day simple moving average is $7.83. BioSyent has a one year low of $5.93 and a one year high of $8.90.

BioSyent Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, March 3rd were paid a $0.0347 dividend. The ex-dividend date was Friday, February 28th. This is an increase from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.77%.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.